Tender detail

Non-exclusive discount agreement for botulinum toxin type A medicines (incobotulinum only), 2026–2028

Summary

DAK-Gesundheit intends to conclude non-exclusive discount agreements with pharmaceutical companies for medicines containing the active ingredient botulinum toxin type A, incobotulinum only (ATC M03AX21). The agreements will run from 1 December 2026 to 30 November 2028 and will end automatically when a new exclusive agreement takes effect.

Reference number
acf59cc8-7323-4d34-b3ec-e97c45932d75
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.